Overall, RIME regulates MLL1‐H3K4me3‐mediated PD‐L1 and IDO‐1 expression, resulting in more cellular resistance to the cytotoxicity of CD8+ T cells and thus facilitating ESCC immune evasion. The gene discussed is IDO1; the disease is esophageal squamous cell carcinoma.